Skip to content

Clinical value of pericapsular nerve group combined with deep piriformis compartment block in patients undergoing total hip replacement surgery

Clinical value of pericapsular nerve group combined with deep piriformis compartment block in patients undergoing total hip replacement surgery

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400089085
Enrollment
Unknown
Registered
2024-09-02
Start date
2024-09-10
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Part I: Pericapsular nerve group (PENG) block combined with lateral femoral cutaneous nerve block group:Pericapsular nerve group (PENG) block : The regional block was performed with the patient in the
Part I: Pericapsular nerve group (PENG) block combined with deep-piriformis compartment and lateral femoral cutaneous nerve block group:Pericapsular nerve group (PENG) block : The regional block was p

Sponsors

Shanghai Sixth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1) 18 years old = age = 80 years old; 2) ASA score ?-?; 3) BMI of 18.5~29.9 kg/m2 [BMI=weight (Kg)/height (m)2]; 4) Patients undergoing elective total hip replacement surgery for primary hip arthrosis/femoral head necrosis on the first unilateral basis; 5) Estimated operating time of 2h or less; 6) Voluntary use of a uniform postoperative analgesic pump; 7) Ethical, voluntary and signed informed consent.

Exclusion criteria

Exclusion criteria: 1) The patient is unable to co-operate with the administration of the nerve block; 2) The patient has compound trauma; 3) History of previous surgery on the affected hip; 4) Contraindications to nerve block (e.g. coagulation disorders/PLT1.5, puncture site infection, local anaesthetic toxicity, neuropathic changes in the lower limbs, etc.); 5) Preoperative coexisting serious cardiopulmonary and cerebral systemic diseases, such as hypertension, coronary artery disease, COPD, asthma, respiratory failure, pulmonary hypertension, severe cardiac arrhythmia (atrial fibrillation, atrioventricular block of degree II and above, sick sinus syndrome, etc.), severe heart valve disease, heart failure, renal failure, stroke and myocardial infarction within 6 months, Alzheimer's disease, Parkinson's disease, psychiatric disorders, OSAS, severe Myasthenia gravis, etc; 6) Patients with drug abuse, chronic heavy alcohol consumption and allergy to anaesthetics; 7) Pre-operative muscle weakness of the affected limb; 8) Patients who refuse or are unable to participate in the study.

Design outcomes

Primary

MeasureTime frame
Numeric Rating Scale score at rest;

Secondary

MeasureTime frame
Numeric Rating Scale score at rest;Numeric Rating Scale score in hip flexion;Muscle strength of lower extremities;Modified Bromage scores;Doses of intra-operative sufentanil;Quality of patient's sleep on the night of surgery;Patient satisfaction with analgesia;Number of presses on analgesic pump postoperatively;Analgesic rescue;

Countries

China

Contacts

Public ContactWang Aizhong

Shanghai Sixth People's Hospital

wangaz@sjtu.edu.cn+86 189 3017 7431

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026